Sitemap

FDA Panel Backs COVID-19 Boosters Only For Elderly And High-Risk

CorD Recommends

Montenegro’s Independence Day Celebrated

Celebrating Montenegro's Independence Day with an Exhibition...

Ireland to Ban Tobacco Sales to Under-21s

Ireland is poised to become the EU's...

Launch of the Council of European Business Associations and Chambers in Serbia

European business associations and bilateral chambers have...

New Joint Venture Forms to Revolutionize Balkan Logistics

In a strategic move to enhance logistics operations in the Western Balkans, Transfera, a leading logistics company in the...

Concept Mercedes-AMG PureSpeed

Exciting, energising and breathtaking – the Mercedes‑AMG PureSpeed concept is the highlight in the run-up to the Formula 1™...

Western Balkans Chambers of Commerce Sign Tourism Cooperation Memorandum in US Congress

A landmark Memorandum of Cooperation has been signed at the US Congress, uniting the Chambers of Commerce of the...

Serbia Ascends as Key Trade Partner for Germany

Serbia is set to become a net exporter to Germany by 2025, overtaking its imports from the economic powerhouse,...

EU Sets Global Standard with World’s First Artificial Intelligence Act

The European Union has taken a pioneering step by adopting the world's first Artificial Intelligence Act, setting a potential...

Dealing the White House a stinging setback, a US government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and instead endorsed the extra vaccine dose only for those who are 65 or older or run a high risk of severe disease.

The twin votes represented a heavy blow to the Biden administration’s sweeping effort, announced a month ago, to shore up nearly all Americans’ protection amid the spread of the highly contagious delta variant.

The nonbinding recommendation — from an influential committee of outside experts who advise the Food and Drug Administration — is not the last word. The FDA will consider the group’s advice and make its own decision, probably within days. And the Centers for Disease Control and Prevention is set to weigh in next week.

In a surprising turn, the advisory panel rejected, 16-2, boosters for almost everyone. Members cited a lack of safety data on extra doses and also raised doubts about the value of mass boosters, rather than ones targeted to specific groups.

Then, in an 18-0 vote, it endorsed extra shots for people 65 and older and those at risk of serious disease. Panel members also agreed that health workers and others who run a high risk of being exposed to the virus on the job should get boosters, too.

That would help salvage part of the White House’s campaign but would still be a huge step back from the far-reaching proposal to offer third shots of both the Pfizer and Moderna vaccines to Americans eight months after they get their second dose.

The White House sought to frame the action as progress

“Today was an important step forward in providing better protection to Americans from COVID-19,” said White House spokesman Kevin Munoz. “We stand ready to provide booster shots to eligible Americans once the process concludes at the end of next week.”

The CDC has said it is considering boosters for older people, nursing home residents and front-line health care workers, rather than all adults.

The FDA and CDC will most likely decide at some later point whether people who received the Moderna or Johnson & Johnson shots should get boosters.

During several hours of vigorous debate Friday, members of the panel questioned the value of offering boosters to almost everybody 16 and over.

“I don’t think a booster dose is going to significantly contribute to controlling the pandemic,” said Dr. Cody Meissner of Tufts University. “And I think it’s important that the main message we transmit is that we’ve got to get everyone two doses.”

Dr. Amanda Cohn of the CDC said, “At this moment it is clear that the unvaccinated are driving transmission in the United States.”

In a statement, Kathrin U. Jansen, Pfizer head of vaccine research and development, said the company continues to believe that boosters will be a “critical tool in the ongoing effort to control the spread of this virus.”

Scientists inside and outside the government have been divided recently over the need for boosters and who should get them, and the World Health Organization has strongly objected to rich nations giving a third round of shots when poor countries don’t have enough vaccine for their first.

While research suggests immunity levels in those who have been vaccinated wane over time and boosters can reverse that, the Pfizer vaccine is still highly protective against severe illness and death, even amid the delta variant.

The unexpected turn of events could reinforce criticism that the Biden administration got out ahead of the science in its push for boosters. President Joe Biden promised early on that his administration would “follow the science,” in the wake of disclosures of political meddling in the Trump administration’s coronavirus response.

The FDA panel’s overwhelming initial rejection came despite full-throated arguments about the need for boosters from both Pfizer and health officials from Israel, which began offering boosters to its citizens in July.

Sharon Alroy-Preis of Israel’s Ministry of Health said the booster dose improves protection tenfold against infection in people 60 and older.

“It’s like a fresh vaccine,” bringing protection back to original levels and helping Israel “dampen severe cases in the fourth wave,” she said.

Representatives for Pfizer argued that it is important to start shoring up immunity before protection begins to erode. A company study of 44,000 people showed effectiveness against symptomatic COVID-19 was 96% two months after the second dose, but had dropped to 84% by around six months.

Both Pfizer and the Israeli representatives faced pushback from panelists. Several were skeptical about the relevance of Israel’s experience to the U.S. Another concern was whether third doses would exacerbate serious side effects, including rare instances of heart inflammation in younger men.

Pfizer pointed to Israeli data from nearly 3 million boosters to suggest side effect rates would be similar to those already reported.

Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia, said he was supportive of a third dose for adults over 60 or 65, but “I really have trouble” supporting it for anyone down to age 16.

While an extra shot would probably at least temporarily reduce cases with mild or no symptoms, “the question becomes what will be the impact of that on the arc of the pandemic, which may not be all that much,” Offit said.

Biden’s top health advisers, including the heads of the FDA and CDC, first announced plans for widespread booster shots in mid-August, setting the week of Sept. 20 as an all-but-certain start date. But that was before FDA staff scientists had completed their own assessments of the data.

COVID-19 vaccinations administered in the US

Earlier this week, two top FDA vaccine reviewers joined a group of international scientists in publishing an editorial rejecting the need for boosters in healthy people. The scientists said studies show the shots are working well.

On Friday, U.S. Surgeon General Dr. Vivek Murthy said the Biden administration announcement was not aimed at pressuring regulators to act but was instead an attempt to be transparent with the public and be prepared in the event that boosters won approval.

“We have always said that this initial plan would be contingent on the FDA and the CDC’s independent evaluation,” Murthy said.

The Biden plan has also raised major ethical concerns about impoverished parts of the world still clamoring for vaccine. But the administration argued that the plan was not an us-or-them choice, noting that the U.S. is supplying large quantities of vaccine to the rest of the globe.

The U.S. has already approved Pfizer and Moderna boosters for certain people with weakened immune systems, such as cancer patients and transplant recipients.

Some Americans, healthy or not, have managed to get boosters, in some cases simply by showing up and asking for a shot. And some health systems already are offering extra doses to high-risk people.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Source: apnews.com by Matthew Perrone And Lauran Neergaard, Photo: AP Photo/Matt Rourke, File

Related Articles

Western Balkans Chambers of Commerce Sign Tourism Cooperation Memorandum in US Congress

A landmark Memorandum of Cooperation has been signed at the US Congress, uniting the Chambers of Commerce of the Western Balkans in a concerted...

TikTok Faces Potential US Ban

President Joe Biden has endorsed a new law that threatens to ban TikTok in the US unless its parent company, ByteDance, sells the app...

1938 Superman Comic Sold for Record $6 Million

A 1938 comic book featuring the first appearance of Superman was sold for a record $6 million to an anonymous collector, announced by the...

White House Calls for Lunar Time Zone

The White House has requested that NASA create a new time zone for the Moon by the end of 2026, as part of a...

Gold Prices Reach Record Highs Amid Central Bank Acquisition Spree

Gold prices have soared to all-time highs, with experts predicting further increases as central banks globally continue to amass gold in large quantities. According...

US Leads Global Oil Production for the Sixth Consecutive Year

The United States has maintained its position as the world's leading oil producer for the sixth year in a row, with an average daily...

China Surpasses the US in International Patent Filings

In a landmark shift that underscores the rapidly evolving landscape of global innovation, China has for the first time significantly outpaced the United States...

US Ambassador Hill Commends Serbia’s Role in Fostering Balkan Unity

In a compelling affirmation of Serbia's efforts towards regional cohesion, Christopher Hill, the US Ambassador to Serbia, praised the nation's initiative in spearheading the...